Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy

Texto completo
Autor(es):
Pompeu Raminelli, Ana Claudia [1] ; Romero, Valeria [2] ; Semreen, Mohammad H. [3, 4] ; Leonardi, Gislaine Ricci [5, 2, 1]
Número total de Autores: 4
Afiliação do(s) autor(es):
[1] Fed Univ Sao Paulo UNIFESP, Med Dept, Sao Paulo - Brazil
[2] Univ Campinas UNICAMP, Med Clin Dept, Campinas, SP - Brazil
[3] Univ Sharjah, Coll Pharm, POB 27272, Sharjah - U Arab Emirates
[4] Univ Sharjah, Sharjah Inst Med Res, POB 27272, Sharjah - U Arab Emirates
[5] Univ Campinas Unicamp, Fac Pharmaceut Sci, Campinas, SP - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo de Revisão
Fonte: Current Medicinal Chemistry; v. 25, n. 31, p. 3703-3718, 2018.
Citações Web of Science: 2
Resumo

Background: The clinical efficacy of the topical tretinoin is widely studied and has been well established for many therapeutic interventions, among some, photoaging, acne, and melasma. However, the side effects, mainly cutaneous irritation, erythema, xerosis and peeling, remain major obstacle to the patient compliance. Besides, the insight regarding the drug delivery profile is essential to understand the therapeutic action of the drug. Methods: Through bibliographic research in databases we highlight further advances and an update on tretinoin delivery systems such as liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, cyclodextrins, nanostructured polymers and other technological systems that reduce its side effects and improve the permeation profile to potentiate efficacy and drug safety on the skin. Results: Pharmaceutical preparations were developed and evaluated for permeability in in vitro models using pig ear, snake, mouse and human skin, and potential for irritation was also verified using release systems for tretinoin and compared to available commercial formulations. Overall results indicated the composition, charge and size of the system influences the tretinoin delivery, modulating the type of release and its retention. Small unilamellar vesicles promoted greater cutaneous delivery of tretinoin. Negative charge, for both liposomes and niosomes, can improve pig skin hydration as well as the tretinoin retention. The quantity of solid lipids and the type of oil used in the composition of solid lipid nanoparticles and nanostructured lipid carriers affected percutaneous drug delivery. Conclusion: As evident from the literature, the tretinoin technological delivery systems consist an innovative and potential management for increasing the patient compliance presenting safety and efficacy. (AU)

Processo FAPESP: 15/02129-6 - Desenvolvimento e avaliação de sistemas de liberação de ácido retinóico constituídos por micropartículas de k-carragena veiculadas em emulsões providas, ou não, de estruturas líquido-cristalinas
Beneficiário:Gislaine Ricci Leonardi
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 13/01118-5 - Avaliação da estabilidade e estudo clínico-laboratorial para verificar e comparar eficácia e segurança do ácido retinóico a 0,05% em creme e a 5% em peelings superficiais
Beneficiário:Gislaine Ricci Leonardi
Modalidade de apoio: Auxílio à Pesquisa - Regular